Predictive molecular alterations of prostate cancer brain metastases based on a companion diagnostic assay
{{output}}
The current first-line treatment standard for patients with metastatic prostate cancer (mPCa), is a combination of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPI), plus the addition of docetaxel for fit patients with high-vol... ...
